We are live on ! Find out more
CC

ClearArc Capital Portfolio holdings

AUM $257M
1-Year Est. Return 33.81%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+33.81%
3 Year Est. Return
+63.41%
5 Year Est. Return
+95.17%
10 Year Est. Return
AUM
$434M
AUM Growth
+$29.2M
Cap. Flow
+$11.3M
Cap. Flow %
2.61%
Top 10 Hldgs %
16.68%
Holding
407
New
26
Increased
249
Reduced
113
Closed
16

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.55M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.1M
3
BP icon
BP
BP
+$798K
4
XRX icon
Xerox
XRX
+$774K
5
AZN icon
AstraZeneca
AZN
+$716K

Sector Composition

Rank Sector Weight
1 Financials 15.83%
2 Technology 14.13%
3 Healthcare 12.38%
4 Energy 11.6%
5 Industrials 10.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
76
MetLife
MET
$62.1B
$1.64M 0.38%
33,044
+1,070
+3% +$50.1K
CPT icon
77
Camden Property Trust
CPT
$11.3B
$1.63M 0.38%
+22,882
New +$1.59M
AIG icon
78
American International
AIG
$41.3B
$1.59M 0.37%
29,122
+131
+0.5% +$6.94K
DRE
79
DELISTED
Duke Realty Corp.
DRE
$1.59M 0.37%
+87,360
New +$1.53M
USB icon
80
US Bancorp
USB
$99.6B
$1.58M 0.36%
36,540
-1,137
-3% -$47.5K
AET
81
DELISTED
Aetna Inc
AET
$1.56M 0.36%
19,204
-3,931
-17% -$298K
DFS
82
DELISTED
Discover Financial Services
DFS
$1.53M 0.35%
24,773
-7,808
-24% -$456K
BIIB icon
83
Biogen
BIIB
$30.7B
$1.53M 0.35%
4,847
+99
+2% +$29.8K
M icon
84
Macy's
M
$6.68B
$1.52M 0.35%
26,253
+5,540
+27% +$322K
BMY icon
85
Bristol-Myers Squibb
BMY
$132B
$1.51M 0.35%
31,142
+417
+1% +$20.6K
TXN icon
86
Texas Instruments
TXN
$261B
$1.5M 0.34%
31,320
+4,246
+16% +$198K
MA icon
87
Mastercard
MA
$493B
$1.49M 0.34%
20,232
-726
-3% -$53.9K
MDT icon
88
Medtronic
MDT
$112B
$1.47M 0.34%
23,091
+213
+0.9% +$12.9K
EOG icon
89
EOG Resources
EOG
$70.7B
$1.46M 0.34%
12,473
-613
-5% -$64.5K
FCX icon
90
Freeport-McMoran
FCX
$97.5B
$1.42M 0.33%
38,797
+1,117
+3% +$38.2K
AES icon
91
AES
AES
$10.5B
$1.39M 0.32%
89,161
+42,707
+92% +$613K
CELG
92
DELISTED
Celgene Corp
CELG
$1.38M 0.32%
16,102
-494
-3% -$37.6K
GLW icon
93
Corning
GLW
$143B
$1.36M 0.31%
61,912
+35,871
+138% +$761K
TFCFA
94
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$1.35M 0.31%
38,548
+123
+0.3% +$4.18K
ALL icon
95
Allstate
ALL
$67.5B
$1.35M 0.31%
23,012
+528
+2% +$30.4K
WMB icon
96
Williams Companies
WMB
$86.1B
$1.33M 0.31%
22,809
+1,226
+6% +$56.8K
WBA
97
DELISTED
Walgreens Boots Alliance
WBA
$1.31M 0.3%
17,674
+379
+2% +$26.5K
HIG icon
98
Hartford Financial Services
HIG
$39.3B
$1.31M 0.3%
36,526
+1,450
+4% +$51K
NEE icon
99
NextEra Energy
NEE
$177B
$1.3M 0.3%
50,724
+1,176
+2% +$28.6K
BKNG icon
100
Booking.com
BKNG
$161B
$1.28M 0.3%
26,675
-875
-3% -$42K

Similar funds

ClearArc Capital's Q2 2014 Portfolio in Review

As of Q2 2014, ClearArc Capital held 407 positions worth $434M, up 7.2% from $405M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

ClearArc Capital's Q2 2014 filing shows 26 new, 249 increased, 113 reduced and 16 closed positions. Its largest new stake was Service Properties Trust: 12,988 shares worth $1.96M. The largest sale was Pfizer, an estimated $1.55M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • ClearArc Capital's largest Q2 2014 buy was Service Properties Trust: 12,988 shares worth $1.96M.
  • ClearArc Capital added most to SLB Ltd in Q2 2014, an estimated $2.08M increase.
  • ClearArc Capital's biggest Q2 2014 reduction was Pfizer, cutting an estimated $1.55M.
  • ClearArc Capital fully exited AstraZeneca in Q2 2014, selling an estimated $716K.
  • ClearArc Capital's ten largest holdings make up 17% of its $434M portfolio in Q2 2014.
  • ClearArc Capital opened 26 new positions and closed 16 in Q2 2014.
  • ClearArc Capital's portfolio value rose 7.2% quarter-over-quarter to $434M.

Based on ClearArc Capital's 13F filing for Q2 2014, filed 14 Aug 2014.